Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
WINDLAS •NSE
Windlas Biotech
₹819.20-5.10 (0.62%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
Performance
Today’s low
815.75
Today’s high
837.70
52 week low
697.40
52 week high
1,097.90
Open price
830.00
Previous close
824.30
Live volume
28,144
Lower circuit
659.45
Upper circuit
989.15
Fundamentals
Market Cap
₹1,694Cr
ROE
11.44%
P/E Ratio(TTM)
25.50
EPS(TTM)
32.20
P/B Ratio
2.92
Dividend Yield
0.78%
Industry P/E
34.11
Book Value
281.35
Debt to Equity
0.06
Face Value
5
Financial performance
MAR '26
Revenue (Cr)
₹243
+2.18%
Profit (Cr)
₹15.99
+6.60%
075150225300
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +17% |
| 3Y CAGR | +18% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -2% |
| 3Y CAGR | +17% |
About
Windlas Biotech Limited is a contract development and manufacturing organization (CDMO) for pharmaceutical formulations.;
CEO/MD
Komal Gupta
Founded in
2001
NSE symbol
WINDLAS
Shareholding Pattern
Jun '25
Sep '25
Dec '25
Mar '26
May '26
Mutual Funds Invested (4)
Similar stocks
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Sai Life SciencesSAILIFE | ₹1,207.90 -10.20 (0.84%) | 25,854.76 | 74.1 | 10.41 | ||
Neuland LaboratoriesNEULANDLAB | ₹17,056.00 -142.00 (0.83%) | 22,038.54 | 60.55 | 11.76 | ||
Piramal PharmaPPLPHARMA | ₹167.20 +3.35 (2.04%) | 21,814.14 | -- | 2.67 | ||
Syngene InternationalSYNGENE | ₹453.50 -5.05 (1.10%) | 18,512.27 | 58.42 | 3.82 |
Livesquawk •
Windlas Biotech faced short-term production issues due to labor strikes in Uttarakhand.
The company confirms that operations have now returned to normal.
Livesquawk •
Windlas Biotech to buy back 4.7 lakh shares at ₹1,000/share in cash.
The buyback will be conducted on a proportionate basis per SEBI rules.
Livesquawk •
Windlas Biotech board approves share buyback at ₹1,000/share via tender offer.
The buyback indicates potential capital return to shareholders.
2026
21
May
Quarterly & Annual Result
Release date
24AprBuybackEx date
24
Apr
Buyback
Ex date
Offer price₹1,000.00
Buyback window30 Apr ‘26 to 7 May ‘26
Ex date24 Apr ‘26
Record date24 Apr ‘26
Announcement date17 Apr ‘26
Buyback typeTender Offer
17AprBuybackAnnounced
17
Apr
Buyback
Announced
Offer price₹1,000.00
Buyback window30 Apr ‘26 to 7 May ‘26
Ex date24 Apr ‘26
Record date24 Apr ‘26
Announcement date17 Apr ‘26
Buyback typeTender Offer
5
Feb
Quarterly Result
Release date
2025
6
Nov
Quarterly Result
Release date
12
Aug
Quarterly Result
Release date
21JulDividendEx date₹5.80per share
21
Jul
Dividend
Ex date
₹5.80
per share
For each share you hold, you will receive ₹5.80
Dividend amount₹5.80 per share
Dividend TypeFinal
Ex Date21 Jul ‘25
Record Date21 Jul ‘25
Announcement date22 May ‘25
22MayDividendAnnounced₹5.80per share
22
May
Dividend
Announced
₹5.80
per share
For each share you hold, you will receive ₹5.80
Dividend amount₹5.80 per share
Dividend TypeFinal
Ex Date21 Jul ‘25
Record Date21 Jul ‘25
Announcement date22 May ‘25
2024
17SepDividendEx date₹5.50per share
17
Sep
Dividend
Ex date
₹5.50
per share
For each share you hold, you will receive ₹5.50
Dividend amount₹5.50 per share
Dividend TypeFinal
Ex Date17 Sep ‘24
Record Date17 Sep ‘24
Announcement date20 May ‘24
Events calendar
View upcoming events in other stocks